Browse by Title

Type here to filter the list

P
Patient Diversity and Personalized Treatment of Non-Small Cell Lung Cancer

Carla Y. Vossen, PhD – Syneos Health ### 1359603###Presenting Author###Senior Director Epidemiology, RWE###Syneos Health###
Presenting Author: Carla Y. Vossen, PhD – Syneos Health
### @@@ Jessica D. Albano, MPH, PhD – Syneos Health ### 1063360###Co-Author###VP Epidemiology, RWE###Syneos Health###
Co-Author: Jessica D. Albano, MPH, PhD – Syneos Health
###
Patient Involvement in the Development and Safe Use of Medicines

Elaine Morrato, DrPH, MPH, FISPE – Loyola University Chicago ### 1046822###Moderator###Dean and Professor, Parkinson School of Health Sciences and Public Health###Loyola University Chicago###
Moderator: Elaine Morrato, DrPH, MPH, FISPE – Loyola University Chicago
### @@@ Priya Bahri, PhD, PGDipEpi, RPh, FISoP – European Medicines Agency ### 1061402###Speaker###Dr.###European Medicines Agency###
Speaker: Priya Bahri, PhD, PGDipEpi, RPh, FISoP – European Medicines Agency
### @@@ Stella Blackburn, MB BS MA MSc FRCP (edin) FISPE FFPM DLSHTM Dip Pharm Med – N/A ### 1397907###Speaker###N/A###N/A###
Speaker: Stella Blackburn, MB BS MA MSc FRCP (edin) FISPE FFPM DLSHTM Dip Pharm Med – N/A
### @@@ Michael Wolf, PhD, MPH – Institute for Public Health and Medicine ### 2033614###Speaker###Associate Vice Chair for Research###Institute for Public Health and Medicine###
Speaker: Michael Wolf, PhD, MPH – Institute for Public Health and Medicine
### @@@ Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc ### 1088147###Speaker###Senior DIrector###Evidera, Inc###
Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc
### @@@ Nicole Mittmann, PhD ### 2125315###Panelist#########
Panelist: Nicole Mittmann, PhD
###
Pediatric Pharmacoepidemiology: Adapting Pharmacoepidemiologic Principles to Studies of the Pediatric Population

Jenny Sun, PhD – Pfizer, Inc. ### 1657990###Lead Speaker###Epidemiologist, Safety Surveillance Research###Pfizer, Inc.###
Lead Speaker: Jenny Sun, PhD – Pfizer, Inc.
### @@@ Tamar Lasky, PhD, FISPE (she/her/hers) – US FDA ### 1046828###Speaker###Senior Advisor on RWE###US FDA###
Speaker: Tamar Lasky, PhD, FISPE (she/her/hers) – US FDA
### she/her/hers @@@ Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA ### 1302719###Speaker###Associate Professor of Pediatrics and Epidemiology###Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA###
Speaker: Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA
### he/him/his @@@ Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States ### 1088178###Speaker###Sr. Director###Merck & Co., Inc., Rahway, NJ, United States###
Speaker: Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States
### he/him/his @@@ Ann W. McMahon, MD, MS, FISPE – Office of Pediatric Therapeutics ### 1142411###Speaker###Team Lead, Science and Innovation Team###Office of Pediatric Therapeutics###
Speaker: Ann W. McMahon, MD, MS, FISPE – Office of Pediatric Therapeutics
###
Performance of different computable phenotypes for the identification of opioid-exposed infants in the electronic health record

Andrew D. Wiese, MPH, PhD – Department of Health Policy, VUMC ### 1062642###Presenting Author###Assistant Professor###Department of Health Policy, VUMC###
Presenting Author: Andrew D. Wiese, MPH, PhD – Department of Health Policy, VUMC
### @@@ Julia Phillippi – Vanderbilt Center for Child Health Policy, VUMC; School of Nursing, Vanderbilt University ### 1991262###Co-Author######Vanderbilt Center for Child Health Policy, VUMC; School of Nursing, Vanderbilt University###
Co-Author: Julia Phillippi – Vanderbilt Center for Child Health Policy, VUMC; School of Nursing, Vanderbilt University
### @@@ Alexandra Muhar, MD – Department of Pediatrics, Division of Neonatology, VUMC ### 1991263###Co-Author###Fellow###Department of Pediatrics, Division of Neonatology, VUMC###
Co-Author: Alexandra Muhar, MD – Department of Pediatrics, Division of Neonatology, VUMC
### @@@ Aleksandra Polic – Department of Obstetrics and Gynecology, VUMC ### 1991264###Co-Author######Department of Obstetrics and Gynecology, VUMC###
Co-Author: Aleksandra Polic – Department of Obstetrics and Gynecology, VUMC
### @@@ Ge Liu – Center for Precision Medicine, VUMC ### 1991265###Co-Author######Center for Precision Medicine, VUMC###
Co-Author: Ge Liu – Center for Precision Medicine, VUMC
### @@@ Sarah Loch – Vanderbilt Center for Child Health Policy, VUMC ### 1991266###Co-Author######Vanderbilt Center for Child Health Policy, VUMC###
Co-Author: Sarah Loch – Vanderbilt Center for Child Health Policy, VUMC
### @@@ Henry H. Ong, PhD – Center for Precision Medicine, VUMC ### 1991267###Co-Author######Center for Precision Medicine, VUMC###
Co-Author: Henry H. Ong, PhD – Center for Precision Medicine, VUMC
### @@@ Wu-Chen Su – Center for Precision Medicine, VUMC ### 1991268###Co-Author######Center for Precision Medicine, VUMC###
Co-Author: Wu-Chen Su – Center for Precision Medicine, VUMC
### @@@ Wei-Qi Wei – Center for Precision Medicine, Department of Biomedical Informatics, VUMC ### 1991269###Co-Author######Center for Precision Medicine, Department of Biomedical Informatics, VUMC###
Co-Author: Wei-Qi Wei – Center for Precision Medicine, Department of Biomedical Informatics, VUMC
### @@@ Stephen W. Patrick, MD, MPHS, MS – Department of Health Policy and Pediatrics, Vanderbilt Center for Child Health Policy, VUMC ### 1360466###Co-Author###Associate Professor of Pediatrics & Health Policy###Department of Health Policy and Pediatrics, Vanderbilt Center for Child Health Policy, VUMC###
Co-Author: Stephen W. Patrick, MD, MPHS, MS – Department of Health Policy and Pediatrics, Vanderbilt Center for Child Health Policy, VUMC
###
Personalizing communication to improve medication adherence using reinforcement learning: a pragmatic randomized trial

Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics ### 1062823###Presenting Author###Assistant Professor###BWH Div of Pharmacoepidemiology and Pharmacoeconomics###
Presenting Author: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Elad Yom-Tov, PhD – Microsoft Research Labs ### 1991336###Co-Author######Microsoft Research Labs###
Co-Author: Elad Yom-Tov, PhD – Microsoft Research Labs
### @@@ Punam Keller, PhD – Dartmouth College ### 1991332###Co-Author######Dartmouth College###
Co-Author: Punam Keller, PhD – Dartmouth College
### @@@ Marie McDonnell, MD – Brigham and Women's Hospital, Endocrinology ### 1991337###Co-Author######Brigham and Women's Hospital, Endocrinology###
Co-Author: Marie McDonnell, MD – Brigham and Women's Hospital, Endocrinology
### @@@ Katherine Crum – Brigham and Women's Hospital, Division of Pharmacoepidemiology and Pharmacoeconomics ### 1991338###Co-Author######Brigham and Women's Hospital, Division of Pharmacoepidemiology and Pharmacoeconomics###
Co-Author: Katherine Crum – Brigham and Women's Hospital, Division of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Gauri Bhatkhande, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1991339###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Gauri Bhatkhande, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Kaitlin Hanken, MPH – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics ### 1991334###Co-Author######Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics###
Co-Author: Kaitlin Hanken, MPH – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Nancy Haff, MD, MPH – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics ### 1991335###Co-Author######Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics###
Co-Author: Nancy Haff, MD, MPH – Brigham and Women's Hospital Division of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Niteesh Choudhry, MD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1655660###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Niteesh Choudhry, MD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
###
Person-generated Health Data: Is Pharmacoepidemiology Ready for this New Frontier?

Darmendra Ramcharran, PhD, MPH – GSK ### 1994710###Lead Speaker###Sr Director, Safety Innovation and Analytics###GSK###
Lead Speaker: Darmendra Ramcharran, PhD, MPH – GSK
### @@@ Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration ### 1991506###Speaker######Food and Drug Administration###
Speaker: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration
### @@@ Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson ### 1088172###Speaker###VP, MedTech Epidemiology and Real-World Data Sciences###Office of the Chief Medical Officer, Johnson & Johnson###
Speaker: Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Speaker###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###
Speaker: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ William G. Dixon, MD PhD – The University of Manchester ### 1062521###Speaker###Professor of Digital Epidemiology###The University of Manchester###
Speaker: William G. Dixon, MD PhD – The University of Manchester
###
Pharmacist Prescribing in Nova Scotia: Uptake and Adaptation to Policy-Related Changes

Jennifer E. Isenor, BSc(Pharm), PharmD, RPh (she/her/hers) – College of Pharmacy, Dalhousie University ### 1991816###Presenting Author###Associate Professor###College of Pharmacy, Dalhousie University###
Presenting Author: Jennifer E. Isenor, BSc(Pharm), PharmD, RPh (she/her/hers) – College of Pharmacy, Dalhousie University
### she/her/hers @@@ Amy Grant – Maritime SPOR Support Unit ### 1993625###Co-Author###Senior Health Policy Researcher###Maritime SPOR Support Unit###
Co-Author: Amy Grant – Maritime SPOR Support Unit
### @@@ Alice Bruce, M.Sc. – Nova Scotia Health Authority (Maritime SPOR SUPPORT Unit) ### 1993626###Co-Author###Research Assistant###Nova Scotia Health Authority (Maritime SPOR SUPPORT Unit)###
Co-Author: Alice Bruce, M.Sc. – Nova Scotia Health Authority (Maritime SPOR SUPPORT Unit)
### @@@ Judith Fisher, BScPhm, PhD – Nova Scotia Department of Health and Wellness ### 1993633###Co-Author######Nova Scotia Department of Health and Wellness###
Co-Author: Judith Fisher, BScPhm, PhD – Nova Scotia Department of Health and Wellness
### @@@ Katelyn M. Frizzell, MSc – Nova Scotia Health ### 1993629###Co-Author######Nova Scotia Health###
Co-Author: Katelyn M. Frizzell, MSc – Nova Scotia Health
### @@@ Elizabeth Jeffers – Maritime SPOR SUPPORT Unit ### 1993630###Co-Author###Research Manager###Maritime SPOR SUPPORT Unit###
Co-Author: Elizabeth Jeffers – Maritime SPOR SUPPORT Unit
### @@@ Rebecca D. Lawrence, BScPharm – Dalhousie University ### 1993632###Co-Author######Dalhousie University###
Co-Author: Rebecca D. Lawrence, BScPharm – Dalhousie University
### @@@ Lihui Liu – MSSU ### 1994187###Co-Author###Senior Data Analyst###MSSU###
Co-Author: Lihui Liu – MSSU
### @@@ Andrea Murphy – Dalhousie University ### 1993634###Co-Author######Dalhousie University###
Co-Author: Andrea Murphy – Dalhousie University
### @@@ Ingrid Sketris, PharmD – Dalhousie University ### 1358680###Co-Author###Professor###Dalhousie University###
Co-Author: Ingrid Sketris, PharmD – Dalhousie University
### @@@ Samuel A. Stewart, PhD – Dalhousie University ### 1092270###Co-Author###Associate Professor###Dalhousie University###
Co-Author: Samuel A. Stewart, PhD – Dalhousie University
### @@@ Shanna C. Trenaman, BScH, BScPharm, MAHSR, ACPR, PhD (she/her/hers) – Dalhousie University ### 1063128###Co-Author###Assistant Professor###Dalhousie University###
Co-Author: Shanna C. Trenaman, BScH, BScPharm, MAHSR, ACPR, PhD (she/her/hers) – Dalhousie University
### she/her/hers @@@ Lisa Woodill – Pharmacy Association of Nova Scotia ### 1993636###Co-Author###Director of Pharmacy Practice###Pharmacy Association of Nova Scotia###
Co-Author: Lisa Woodill – Pharmacy Association of Nova Scotia
###
Pharmacoepi Toolbox for Confounding Control

Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark ### 1062967###Co-Moderator###Professor of clinical pharmacology###University of Southern Denmark###
Co-Moderator: Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark
### he/him/his @@@ Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands ### 1655571###Co-Moderator###Assistant Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands###
Co-Moderator: Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
### she/her/hers
Pharmacoepidemiologic Approaches to Studying Drug-Drug Interactions

Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School ### 1655839###Lead Speaker###Assistant Professor###Brigham and Women's Hospital and Harvard Medical School###
Lead Speaker: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Todd Miano, PharmD, PhD – Perelman School of Medicine at the University of Pennsylvania ### 1357966###Speaker###Assistant Professor of Epidemiology###Perelman School of Medicine at the University of Pennsylvania###
Speaker: Todd Miano, PharmD, PhD – Perelman School of Medicine at the University of Pennsylvania
### @@@ Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité ### 1062567###Speaker###Associate Professor###Institute of Clinical Pharmacology and Toxicology, Charité###
Speaker: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité
### he/him/his
Pharmacoepidemiologist's Toolbox for Professional Empowerment

Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1655344###Moderator###Assistant Professor###University of North Carolina at Chapel Hill###
Moderator: Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 1360272###Moderator###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc.###
Moderator: Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hers @@@ Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania ### 1359970###Speaker###Associate Professor of Medicine and Epidemiology###Perelman School of Medicine at the University of Pennsylvania###
Speaker: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/his @@@ Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration ### 1991506###Speaker######Food and Drug Administration###
Speaker: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Speaker###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###
Speaker: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his
Pharmacogenomics & Precision Medicine for Pharmacoepidemiologists

Amalia M. Issa, PhD, MPH, FISPE ### 1046825###Lead Speaker#########
Lead Speaker: Amalia M. Issa, PhD, MPH, FISPE
### @@@ Gillian Bartlett-Esquilant, PhD, FISPE – University of Missouri School of Medicine ### 1086987###Lead Speaker###Associate Dean###University of Missouri School of Medicine###
Lead Speaker: Gillian Bartlett-Esquilant, PhD, FISPE – University of Missouri School of Medicine
### @@@ Stephen E. Kimmel, MD, MSCE, FISPE – University of Florida ### 1359594###Speaker###Professor of Epidemiology###University of Florida###
Speaker: Stephen E. Kimmel, MD, MSCE, FISPE – University of Florida
### @@@ Anke-Hilse Maitland-van der Zee, PharmD, PhD (she/her/hers) – Amsterdam UMC ### 1088169###Speaker###Professor of Precision Medicine in Respiratory Disease###Amsterdam UMC###
Speaker: Anke-Hilse Maitland-van der Zee, PharmD, PhD (she/her/hers) – Amsterdam UMC
### she/her/hers @@@ Bruce C. Carleton, PharmD, FCP, FISPE – University of British Columbia ### 1046820###Speaker###Professor###University of British Columbia###
Speaker: Bruce C. Carleton, PharmD, FCP, FISPE – University of British Columbia
###
Pharmacovigilance and Signal Detection

Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1062626###Lead Speaker###Assistant Professor###Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###
Lead Speaker: Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### she/her/hers @@@ Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1358805###Lead Speaker###Director, Division of Pharmacovigilance I###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###
Lead Speaker: Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### she/her/hers @@@ G. Niklas Norén, PhD – Uppsala Monitoring Centre ### 1062637###Speaker###Chief Science Officer###Uppsala Monitoring Centre###
Speaker: G. Niklas Norén, PhD – Uppsala Monitoring Centre
### @@@ Greg Powell, PharmD, MBA (he/him/his) – GlaxoSmithKline ### 1063261###Speaker###Senior Director, Safety and Clinical Innovation###GlaxoSmithKline###
Speaker: Greg Powell, PharmD, MBA (he/him/his) – GlaxoSmithKline
### he/him/his
Pharmacovigilance: Follow the Evidence

Nelson Pace, PhD, SM – AbbVie, Inc. ### 1658893###Co-Moderator###Director of Epidemiology###AbbVie, Inc.###
Co-Moderator: Nelson Pace, PhD, SM – AbbVie, Inc.
### @@@ Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 1360272###Co-Moderator###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc.###
Co-Moderator: Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hers
Potential Drug-Drug Interactions Among U.S. Adults Treated With Nirmatrelvir/Ritonavir (Paxlovid): A Cross-sectional Study Of The National COVID Cohort Collaborative (N3C)

Xuya(Rayna) Xiao, MHS (she/her/hers) – Johns Hopkins Bloomberg School of Public Health ### 1991149###Presenting Author###Research analyst###Johns Hopkins Bloomberg School of Public Health###
Presenting Author: Xuya(Rayna) Xiao, MHS (she/her/hers) – Johns Hopkins Bloomberg School of Public Health
### she/her/hers @@@ Hemalkumar B. Mehta, PhD, MS – Johns Hopkins Bloomberg School of Public Health ### 1093588###Co-Author###Assistant Professor###Johns Hopkins Bloomberg School of Public Health###
Co-Author: Hemalkumar B. Mehta, PhD, MS – Johns Hopkins Bloomberg School of Public Health
### @@@ Jill Curran, MS – Johns Hopkins Bloomberg School of Public Health ### 1659092###Co-Author###Research Program Manager###Johns Hopkins Bloomberg School of Public Health###
Co-Author: Jill Curran, MS – Johns Hopkins Bloomberg School of Public Health
### @@@ Brian T. Garibaldi – Johns Hopkins University School of Medicine ### 1302716###Co-Author###Associate Professor###Johns Hopkins University School of Medicine###
Co-Author: Brian T. Garibaldi – Johns Hopkins University School of Medicine
### @@@ G. Caleb Alexander, MD, MS – Johns Hopkins Bloomberg School of Public Health ### 1991150###Co-Author###Professor of Epidemiology and Medicine###Johns Hopkins Bloomberg School of Public Health###
Co-Author: G. Caleb Alexander, MD, MS – Johns Hopkins Bloomberg School of Public Health
###
Practical Skills In Protocol Writing and Statistical Analytic Programming Relevant to Studies Generating Real-World Evidence (RWE)

Natasha Pratt, PhD (she/her/hers) – U.S. Food and Drug Administration ### 2015392###Lead Speaker###Master Epidemiologist###U.S. Food and Drug Administration###
Lead Speaker: Natasha Pratt, PhD (she/her/hers) – U.S. Food and Drug Administration
### she/her/hers @@@ Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY ### 1360408###Speaker###Director, Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc., Tarrytown, NY###
Speaker: Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
### he/him/his @@@ Jessica Jalbert, PhD (she/her/hers) – Regeneron ### 2015396###Speaker###Executive Director - HEOR-Epidemiology###Regeneron###
Speaker: Jessica Jalbert, PhD (she/her/hers) – Regeneron
### she/her/hers @@@ Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ ### 1302720###Speaker###Professor of Medicine and Epidemiology###Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ###
Speaker: Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
### @@@ Ximena Camacho, MMath (she/her/hers) – UNSW Sydney ### 1658324###Speaker###PhD candidate###UNSW Sydney###
Speaker: Ximena Camacho, MMath (she/her/hers) – UNSW Sydney
### she/her/hers @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Speaker###Associate Director for Science###US Food and Drug Administration###
Speaker: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration ### 1358505###Speaker###Senior Epidemiologist###US Food and Drug Administration###
Speaker: Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration
### @@@ Olivier Humblet ### 2125427###Speaker#########
Speaker: Olivier Humblet
###
Prenatal exposure to selective serotonin reuptake inhibitors and risk of Disorders of Gut-Brain Interaction in the offspring

Helene Kildegaard, MD – Clinical Pharmacology, Pharmacy and Environmental Medicine, Dept. of Puiblic Health, University of Southern Denmark ### 1358299###Presenting Author###MD###Clinical Pharmacology, Pharmacy and Environmental Medicine, Dept. of Puiblic Health, University of Southern Denmark###
Presenting Author: Helene Kildegaard, MD – Clinical Pharmacology, Pharmacy and Environmental Medicine, Dept. of Puiblic Health, University of Southern Denmark
### @@@ Mette Bliddal, PhD – University of Southern Denmark ### 1062809###Co-Author###Associate professor###University of Southern Denmark###
Co-Author: Mette Bliddal, PhD – University of Southern Denmark
### @@@ Martin Thomsen Ernst – University of Southern Denmark ### 1358301###Co-Author######University of Southern Denmark###
Co-Author: Martin Thomsen Ernst – University of Southern Denmark
### @@@ Rikke Wesselhoeft, MD – Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark ### 1062690###Co-Author###Associate Professor###Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark###
Co-Author: Rikke Wesselhoeft, MD – Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark
### @@@ Anton Pottegård, PhD, MSc – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062518###Co-Author###Professor###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###
Co-Author: Anton Pottegård, PhD, MSc – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
### @@@ Kara G. Margolis, MD – New York University College of Dental Medicine ### 1991458###Co-Author###Associate Professor of Molecular Pathobiology and Pediatrics###New York University College of Dental Medicine###
Co-Author: Kara G. Margolis, MD – New York University College of Dental Medicine
### @@@ Ardesheer Talati, PhD – Columbia University ### 1657812###Co-Author######Columbia University###
Co-Author: Ardesheer Talati, PhD – Columbia University
###
Prenatal Exposure to Valproic Acid in the United States

Nicole E. Smolinski, PharmD – Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida ### 1358688###Presenting Author###Graduate Student###Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida###
Presenting Author: Nicole E. Smolinski, PharmD – Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
### @@@ Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson ### 1084118###Co-Author###Manager###Janssen Research & Development, Johnson & Johnson###
Co-Author: Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson
### he/him/his @@@ Thuy N. Thai, PhD (she/her/hers) – Harvard Pilgrim Health Care Institute/Harvard Medical School ### 1062542###Co-Author###Research Scientist###Harvard Pilgrim Health Care Institute/Harvard Medical School###
Co-Author: Thuy N. Thai, PhD (she/her/hers) – Harvard Pilgrim Health Care Institute/Harvard Medical School
### she/her/hers @@@ Sebastian Jugl, BPharm, RPh (he/him/his) – University of Florida ### 1063291###Co-Author###PhD Student###University of Florida###
Co-Author: Sebastian Jugl, BPharm, RPh (he/him/his) – University of Florida
### he/him/his @@@ Celeste Ewig, PharmD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida ### 1657495###Co-Author###Graduate Assistant###Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida###
Co-Author: Celeste Ewig, PharmD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
### @@@ Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###
Co-Author: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
###
Prescribing of Opioid Analgesics in Germany: Opposite Trends When Different Quantification Measures Are Used

Oliver Scholle, PhD – Leibniz Institute for Prevention Research and Epidemiology – BIPS ### 1062768###Presenting Author###Postdoctoral research fellow###Leibniz Institute for Prevention Research and Epidemiology – BIPS###
Presenting Author: Oliver Scholle, PhD – Leibniz Institute for Prevention Research and Epidemiology – BIPS
### @@@ Kathrin Jobski, PhD – Department of Health Services Research, Carl von Ossietzky University Oldenburg ### 1991250###Co-Author######Department of Health Services Research, Carl von Ossietzky University Oldenburg###
Co-Author: Kathrin Jobski, PhD – Department of Health Services Research, Carl von Ossietzky University Oldenburg
### @@@ Jost Viebrock – Leibniz Institute for Prevention Research and Epidemiology – BIPS ### 1661022###Co-Author######Leibniz Institute for Prevention Research and Epidemiology – BIPS###
Co-Author: Jost Viebrock – Leibniz Institute for Prevention Research and Epidemiology – BIPS
### @@@ Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062658###Co-Author###Prof. Dr. sc. hum.###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Co-Author: Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS
###
Prescription Medication Use During Pregnancy in the United States from 2011 to 2019

Omar Mansour, MHS – Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States ### 1655759###Presenting Author###PhD Student###Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States###
Presenting Author: Omar Mansour, MHS – Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States
### @@@ Rienna Russo – Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States ### 1991716###Co-Author######Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States###
Co-Author: Rienna Russo – Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States
### @@@ Loreen Straub, MD MS – Brigham and Women's Hospital/Harvard Medical School ### 1062604###Co-Author###Research Fellow###Brigham and Women's Hospital/Harvard Medical School###
Co-Author: Loreen Straub, MD MS – Brigham and Women's Hospital/Harvard Medical School
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
### @@@ Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University ### 1093997###Co-Author###Professor of Epidemiology###Harvard University###
Co-Author: Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University
###
Prevalence of probable Alzheimer’s disease in Veteran patients based on clinical notes from electronic health records

Donald R. Miller, ScD – EOS ### 1991692###Presenting Author###Director###EOS###
Presenting Author: Donald R. Miller, ScD – EOS
### @@@ Guneet Jasuja, PhD – Center for Healthcare Organization and Implementation Research ### 1991718###Co-Author###Research Scientist###Center for Healthcare Organization and Implementation Research###
Co-Author: Guneet Jasuja, PhD – Center for Healthcare Organization and Implementation Research
### @@@ Byron Aguilar, PhD – Geriatric Research Education and Clinical Center, VA Bedford Healthcare System ### 1991720###Co-Author###Research Scientist###Geriatric Research Education and Clinical Center, VA Bedford Healthcare System###
Co-Author: Byron Aguilar, PhD – Geriatric Research Education and Clinical Center, VA Bedford Healthcare System
### @@@ Xuyang Li, BS – Department of Biomedical Engineering, Johns Hopkins University ### 1991721###Co-Author###Doctoral student###Department of Biomedical Engineering, Johns Hopkins University###
Co-Author: Xuyang Li, BS – Department of Biomedical Engineering, Johns Hopkins University
### @@@ Ekaterina Shishova, PhD – Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell ### 1991722###Co-Author###Research Scientist###Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell###
Co-Author: Ekaterina Shishova, PhD – Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell
### @@@ Dan Berlowitz, MPH MD – Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell ### 1991723###Co-Author###Chair and Professor###Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell###
Co-Author: Dan Berlowitz, MPH MD – Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell
### @@@ Peter Morin, MD PhD – Department of Neurology, Boston University School of Medicine ### 1991724###Co-Author###Clinical Associate Professor###Department of Neurology, Boston University School of Medicine###
Co-Author: Peter Morin, MD PhD – Department of Neurology, Boston University School of Medicine
### @@@ Maureen K. O'Conner, PsyD – Department of Neurology, Boston University School of Medicine ### 1991725###Co-Author###Assistant Professor###Department of Neurology, Boston University School of Medicine###
Co-Author: Maureen K. O'Conner, PsyD – Department of Neurology, Boston University School of Medicine
### @@@ Andrew Nguyen, M.A. – VA Bedford Healthcare System ### 1991726###Co-Author###Research Associate###VA Bedford Healthcare System###
Co-Author: Andrew Nguyen, M.A. – VA Bedford Healthcare System
### @@@ Cindy Christiansen, PhD – Goldman School of Dental Medicine, Boston University ### 1991727###Co-Author###Professor###Goldman School of Dental Medicine, Boston University###
Co-Author: Cindy Christiansen, PhD – Goldman School of Dental Medicine, Boston University
### @@@ Raymond Zhang, MD PhD – Epidemiology, Biostatistics and Occupational Health, McGill University ### 1991728###Co-Author###Adjunct Professor###Epidemiology, Biostatistics and Occupational Health, McGill University###
Co-Author: Raymond Zhang, MD PhD – Epidemiology, Biostatistics and Occupational Health, McGill University
### @@@ Amir Abbas Tahami Monfared, MD, PhD – Eisai Inc., USA ### 1991392###Co-Author###Executive Director###Eisai Inc., USA###
Co-Author: Amir Abbas Tahami Monfared, MD, PhD – Eisai Inc., USA
### @@@ Quanwu Zhang, PhD – Eisai Inc., USA ### 1991391###Co-Author###Senior Director###Eisai Inc., USA###
Co-Author: Quanwu Zhang, PhD – Eisai Inc., USA
### @@@ Weiming Xia, PhD – Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine ### 1991729###Co-Author###Professor###Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine###
Co-Author: Weiming Xia, PhD – Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine
###
Principled Approaches To Handle Partially Observed Confounder Data From Electronic Health Records: A Plasmode Simulation Study

Janick Weberpals, RPh, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1991181###Presenting Author###Instructor in Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Presenting Author: Janick Weberpals, RPh, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Sudha R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1088164###Co-Author###Assistant Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###
Co-Author: Sudha R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### she/her/hers @@@ Pamela A. Shaw – Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, WA ### 1991182###Co-Author######Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, WA###
Co-Author: Pamela A. Shaw – Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, WA
### @@@ Hana Lee, PhD – Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1655520###Co-Author######Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration###
Co-Author: Hana Lee, PhD – Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Bradley G. Hammill, DrPH (he/him/his) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1991183###Co-Author###Associate Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###
Co-Author: Bradley G. Hammill, DrPH (he/him/his) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### he/him/his @@@ Darren Toh, ScD – Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA ### 1358101###Co-Author######Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA###
Co-Author: Darren Toh, ScD – Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
### @@@ John G. Connolly, ScD – Harvard Pilgrim Health Care Institute ### 1063038###Co-Author###Research Scientist###Harvard Pilgrim Health Care Institute###
Co-Author: John G. Connolly, ScD – Harvard Pilgrim Health Care Institute
### @@@ Kimberly J. Dandreo – Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA ### 1991184###Co-Author######Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA###
Co-Author: Kimberly J. Dandreo – Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA
### @@@ Luke Zabotka – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1659303###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Luke Zabotka – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Fang Tian – Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD ### 1659617###Co-Author######Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD###
Co-Author: Fang Tian – Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD
### @@@ Wei Liu – Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD ### 1358274###Co-Author######Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD###
Co-Author: Wei Liu – Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD
### @@@ Jie Li, PhD – US Food and Drug Administration ### 1062564###Co-Author###Associate Director for RWE at Office of Surveillance and Epidemiology, CDER###US Food and Drug Administration###
Co-Author: Jie Li, PhD – US Food and Drug Administration
### @@@ José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1991185###Co-Author###Senior Pharmacist/Pharmacoepidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###
Co-Author: José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1302713###Co-Author###Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1093509###Co-Author###Assistant Professor ###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
###
Principles of Pharmacoepidemiology

Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University ### 1046831###Lead Speaker###Professor and Director###Center for Pharmacoepidemiology and Treatment Science, Rutgers University###
Lead Speaker: Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
### he/him/his @@@ Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Speaker###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###
Speaker: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
### @@@ Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062583###Speaker###Senior scientist###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Speaker: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers
Privacy-Preserving Solutions for Real-World Data (RWD) Access and Collaboration: Challenges & Opportunities

Echo Wang, DrPH, MSPH (she/her/hers) – Merck & Co. Inc. ### 1655735###Lead Speaker###Director, Data Strategy & Partnerships###Merck & Co. Inc.###
Lead Speaker: Echo Wang, DrPH, MSPH (she/her/hers) – Merck & Co. Inc.
### she/her/hers @@@ Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States ### 1088178###Speaker###Sr. Director###Merck & Co., Inc., Rahway, NJ, United States###
Speaker: Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States
### he/him/his @@@ Jeremy A. Rassen, ScD, FISPE – Aetion ### 1062955###Speaker###Co-founder and President###Aetion###
Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
### @@@ Randi Foraker, PhD, MA – Washington University School of Medicine ### 1655736###Speaker###Professor of Medicine###Washington University School of Medicine###
Speaker: Randi Foraker, PhD, MA – Washington University School of Medicine
### @@@ Lucy Mosquera, MSc (she/her/hers) – Replica Analytics ### 2043844###Speaker###Sr Director Data Science###Replica Analytics###
Speaker: Lucy Mosquera, MSc (she/her/hers) – Replica Analytics
### she/her/hers @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656###Speaker###Head of Real World Evidence###European Medicines Agency###
Speaker: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
### @@@ Khaled El Emam – Replica Analytics ### 1655739###Speaker######Replica Analytics###
Speaker: Khaled El Emam – Replica Analytics
###
Projected Impact of Weight-Loss Medication Use on Racial-Ethnic Disparities in Adolescent Obesity

Mary Ellen Vajravelu, MD, MSHP (she/her/hers) – University of Pittsburgh School of Medicine ### 1991495###Presenting Author###Assistant Professor of Pediatrics and Epidemiology###University of Pittsburgh School of Medicine###
Presenting Author: Mary Ellen Vajravelu, MD, MSHP (she/her/hers) – University of Pittsburgh School of Medicine
### she/her/hers @@@ Patricia Chu, MD – Division of Endocrinology and Diabetes, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania ### 1991496###Co-Author######Division of Endocrinology and Diabetes, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania###
Co-Author: Patricia Chu, MD – Division of Endocrinology and Diabetes, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania
### @@@ David A. Frank, MPH – Department of Epidemiology, University of Pittsburgh School of Public Health ### 1991203###Co-Author###Student###Department of Epidemiology, University of Pittsburgh School of Public Health###
Co-Author: David A. Frank, MPH – Department of Epidemiology, University of Pittsburgh School of Public Health
### @@@ Ravy K. Vajravelu, MD MSCE – Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine Staff Gastroenterologist and Core Investigator, VA Pittsburgh Healthcare System ### 1991214###Co-Author###Assistant Professor of Medicine###Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine Staff Gastroenterologist and Core Investigator, VA Pittsburgh Healthcare System###
Co-Author: Ravy K. Vajravelu, MD MSCE – Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine Staff Gastroenterologist and Core Investigator, VA Pittsburgh Healthcare System
###
Propensity Scores in Pharmacoepidemiology

John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology ### 1046832###Lead Speaker###Chief Scientific Officer###Optum Epidemiology###
Lead Speaker: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
### @@@ Jeremy A. Rassen, ScD, FISPE – Aetion ### 1062955###Speaker###Co-founder and President###Aetion###
Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
###